Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeKA ImagingKA Imaging Signs with Alpha Imaging for Distribution in the USA

KA Imaging Signs with Alpha Imaging for Distribution in the USA

KA Imaging has signed a distribution agreement in the USA with Alpha Imaging. Hospitals, medical facilities, and practices from 14 states can now acquire Reveal™ 35C through Alpha Imaging, one of the largest distributors of medical imaging equipment in the country.

Robert Moccia, VP of Sales for KA Imaging in the United States and Canada, is thrilled to have made this agreement.

“Our partnership with Alpha is a big step towards KA Imaging’s vision to bring innovative X-ray everywhere. Alpha Imaging’s 30+ year track record of providing Imaging equipment to some of the most prestigious healthcare institutions in the US gives KA Imaging the access and credibility to excite the market with our technology and ultimately improve patient care” said Moccia.

Michael Perrico, CEO of Alpha Imaging, said: “The addition of KA Imaging’s Reveal 35C adds yet another advanced imaging technology to our robust portfolio of medical imaging offerings. Single exposure subtracted chest imaging will provide clients with a low dose and cost-effective alternative to traditional dual-energy systems. We are excited to partner with KA Imaging.”

Reveal 35C is the world’s first and only portable dual-energy X-ray detector. The detector provides radiologists with three unobstructed images in a single shot that are free from motion artifacts. Reveal is currently being used in two clinical trials, for detecting both lung cancer and pneumonia (including COVID-19) with great initial success.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy